Ontology highlight
ABSTRACT: Objectives
The aim of this review is to summarise the latest evidence on efficacy and safety of treatments for new-onset atrial fibrillation (NOAF) in critical illness.Participants
Critically ill adult patients who developed NOAF during admission.Primary and secondary outcomes
Primary outcomes were efficacy in achieving rate or rhythm control, as defined in each study. Secondary outcomes included mortality, stroke, bleeding and adverse events.Methods
We searched MEDLINE, EMBASE and Web of Knowledge on 11 March 2019 to identify randomised controlled trials (RCTs) and observational studies reporting treatment efficacy for NOAF in critically ill patients. Data were extracted, and quality assessment was performed using the Cochrane Risk of Bias Tool, and an adap
SUBMITTER: O'Bryan LJ
PROVIDER: S-EPMC7202704 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature